Negara: Jepang
Bahasa: Inggris
Sumber: すりの適正使用協議会 RAD-AR Council, Japan
Agalsidase beta (genetical recombination) [agalsidase beta biosimilar 1]
Sumitomo Pharma Co.,Ltd.
Agalsidase beta (genetical recombination) [agalsidase beta biosimilar 1]
Injection
Drug Information Sheet("Kusuri-no-Shiori") Injection Revised: 10/2022 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: AGALSIDASE BETA BS I.V. INFUSION 5MG [JCR] ACTIVE INGREDIENT: Agalsidase beta (genetical recombination) [agalsidase beta biosimilar 1] DOSAGE FORM: Injection IMPRINT OR PRINT ON WRAPPING: EFFECTS OF THIS MEDICINE This medicine supplements the human enzyme alfa-galactosidase. It is usually used to treat Fabry disease. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. ・If you are pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE) ・ Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional )) ・In general, this medicine is administered by intravenous drip infusion every two weeks. ・The treatment period with this medicine depends on your symptoms. PRECAUTIONS WHILE TAKING THIS MEDICINE POSSIBLE ADVERSE REACTIONS TO THIS MEDICINE The most commonly reported adverse reactions include chills, fever and cough. If any of these symptoms occur, consult with your doctor or pharmacist. THE SYMPTOMS DESCRIBED BELOW ARE RARELY SEEN AS INITIAL SYMPTOMS OF THE ADVERSE REACTIONS INDICATED IN BRACKETS. IF ANY OF THESE SYMPTOMS OCCUR, STOP TAKING THIS MEDICINE AND SEE Baca dokumen lengkapnya